RxDoctor Payments Data

Henry Biggs, DO

Adult Reconstructive Orthopaedic Surgery · Naples, FLNPI 1558326538

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (58.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Nextstep Arthropedix, LLC at 58.7% of the total. Reporting peaked in 2019 at $43,739 and has fallen 99.1% since, to $375 in 2025.

$49,768in general payments, 2019–2025

Across 58 payments — averaging $858.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nextstep Arthropedix, LLC$29K
  • Corin USA$9K
  • Conformis, Inc.$5K
  • UOC USA Inc$4K
  • Maxx Orthopedics, Inc.$962
  • Smith+Nephew$349
  • plus $1K from 10 others
$5,000in research payments, 2019–2025

Across 2 payments — averaging $2500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Maxx Orthopedics, Inc.$5K
$39,101in ownership & investment interests, 2019–2025

Across 6 payments — averaging $6516.79 each. An ownership or investment interest held by the physician or an immediate family member.

  • Catalyst Orthoscience$39K

What the payments were for

  • Royalty or licence$29,19159%
  • Consulting fees$13,97528%
  • Speaking & faculty fees$2,0004%
  • Travel & lodging$1,3753%
  • Food & beverage$2,9936%
  • Education$2330%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$49,768 in reported general payments places this provider in the 75th percentile of 96 adult reconstructive orthopaedic surgery providers in Florida.

See all adult reconstructive orthopaedic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$1,175,226
Medicare patients
1,243
Services billed
13,982

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen339$7,478
Celecoxib328$6,451
Tranexamic Acid222$4,067
Ondansetron Hcl511$1,739
Zolpidem Tartrate544$1,693
Tramadol Hcl301$1,328
Cephalexin161$1,124
Diclofenac Sodium ErDiclofenac Sodium31$710
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen42$556
Hydromorphone Hcl58$376
Dexamethasone17$213
Meloxicam59$142
Amoxicillin48$104
Alprazolam25$72
Methylprednisolone12$70

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Naples

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →